Endotronix inks $45 mln Series D
Lisle, Illinois-based Endotronix Inc, a digital health focused on advancing the treatment of heart failure, has raised $45 million in Series D funding. LSP led the round with participation from other investors that included Aperture Venture Partners, BioVentures Investors, Lumira Ventures, OSF Ventures, Seroba Life Sciences, SV Health Investors and Wanxiang Healthcare Investments.
14 September 2018•1 min read
